2343P Evolution of circulating tumour DNA analysis in France over 5 years

Autor: Herbreteau, G., Rouleau, E., Bellocq, J-P., Fetique, D., Egele, C., Taverniers, S., Dequeker, E., Lacroix, L., Denis, M.G.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S1194-S1194

94P - Two years of BRCA1 and BRCA2 somatic external quality assessment with Gen&Tiss scheme in France

Autor: Dufraing, K., Garrec, C., Egele, C., Keppens, C., Chiesa, J., Lamy, A., Lacroix, L., Harlé, A., Pascal, R., Van Casteren, K., Fetique, D., Dequeker, E., Bellocq, J.-P., Rouleau, E.

Publikováno v: In Annals of Oncology October 2019 30 Supplement 5:v26-v27

PMD4 - Evaluation of Breast Cancer HER2 Status Accuracy Using A Predictive Model Based on Her-France Real World National Database

Autor: Egele, C, Pau, D, Rabut, J, Fetique, D, Martin, J, Bellocq, J

Publikováno v: In Value in Health November 2016 19(7):A685-A685

Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.

Autor: Dequeker EM; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven-University of Leuven, Leuven, Belgium. Electronic address: els.dequeker@med.kuleuven.be., Keppens C; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven-University of Leuven, Leuven, Belgium., Egele C; French Association of Quality Assurance in Pathology (AFAQAP), Hospital d'Hautepierre, Strasbourg, France., Delen S; Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, KU Leuven-University of Leuven, Leuven, Belgium., Lamy A; Laboratory of Somatic Tumor Genetics, Hospital Charles Nicolle, Rouen, France., Lemoine A; Department of Somatic Genetics, Hospital Paul Brousse, Villejuif, France., Sabourin JC; Laboratory of Somatic Tumor Genetics, Hospital Charles Nicolle, Rouen, France., Andrieu C; Unit of Constitutional and Somatic Genetics, Genetics Department, Institut Curie, Paris, France., Ligtenberg M; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Fetique D; French Association of Quality Assurance in Pathology (AFAQAP), Hospital d'Hautepierre, Strasbourg, France., Tops B; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Descarpentries C; Molecular Biology Cancer Platform from the region Nord Pas de Calais, Lille, France., Blons H; Biochemistry Unit, Department of Biology, European Hospital Georges Pompidou, Paris, France., Denoux Y; Department of Pathology, Foch Hospital, Suresnes, France., Aube C; Molecular Pathology Unit, Department of Biopathology, Center Jean Perrin, Clermont-Ferrand, France., Penault-Llorca F; Molecular Pathology Unit, Department of Biopathology, Center Jean Perrin, Clermont-Ferrand, France., Hofman P; Laboratories of Clinical and Experimental Pathology, Pasteur Hospital, CHU de Nice, Nice, France., Leroy K; Department of Pathology, Hospital Henri Mondor, Creteil, France., Le Marechal C; Laboratory of Anatomical Pathology, Molecular Genetics and Histocompatibility, Platform of Molecular Cancer Genetics, CHRU Brest, Brest, France., Doucet L; Laboratory of Anatomical Pathology, Molecular Genetics and Histocompatibility, Platform of Molecular Cancer Genetics, CHRU Brest, Brest, France., Duranton-Tanneur V; Solid Tumor Genetics, Pasteur Hospital, CHU de Nice, Nice, France., Pedeutour F; Solid Tumor Genetics, Pasteur Hospital, CHU de Nice, Nice, France., Soubeyran I; Molecular Pathology Unit, Institute Bergonié, Bordeaux, France., Côté JF; Laboratory of Anatomical Pathology, Hospital Tenon, Paris, France., Emile JF; Department of Pathology, Hospital Ambroise Paré, Boulogne-Billancourts, France., Vignaud JM; Laboratory of Anatomical Pathology, CHU Nancy-Central Hospital, Nancy, France., Monhoven N; Laboratory of Anatomical Pathology, CHU Nancy-Central Hospital, Nancy, France., Haddad V; Laboratory of Molecular Biology, Department of Biopathology, Center Léon Bérard, Lyon, France., Laurent-Puig P; Biochemistry Unit, Department of Biology, European Hospital Georges Pompidou, Paris, France., van Krieken H; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Nowak F; National Cancer Institute (INCa), Boulogne-Billancourt, France., Lonchamp E; National Cancer Institute (INCa), Boulogne-Billancourt, France., Bellocq JP; French Association of Quality Assurance in Pathology (AFAQAP), Hospital d'Hautepierre, Strasbourg, France., Rouleau E; Unit of Constitutional and Somatic Genetics, Genetics Department, Institut Curie, Paris, France.

Publikováno v: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2016 Mar; Vol. 18 (2), pp. 205-14. Date of Electronic Publication: 2016 Jan 02.

Reply to Torlakovic, E.; Normanno, N. Comment on "Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. J. Mol. Pathol. 2024, 5 , 1–10".

Autor: Sheffield, Brandon S.^1,2 brandon.sheffield@williamoslerhs.ca, Bisson, Kassandra R.^1,2, Beharry, Andrea², Carter, Michael D.³, Dudani, Shaan⁴, Loree, Jonathan M.⁵, Snow, Stephanie⁶, Won, Jennifer R.¹, Yip, Stephen⁷, Garratt, John G.¹

Publikováno v: Journal of Molecular Pathology. Sep2024, Vol. 5 Issue 3, p262-263. 2p.